Skip header and navigation

Refine By

1468 records – page 1 of 147.

[Preparation of alcohol-aqueous solutions by a gravivolumetric method]

https://arctichealth.org/en/permalink/ahliterature13059
Source
Farm Zh. 1979 Sep-Oct;(5):71-3
Publication Type
Article

Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.

https://arctichealth.org/en/permalink/ahliterature287185
Source
PLoS One. 2017;12(11):e0187423
Publication Type
Article
Date
2017
Author
Guttorm Raknes
Lars Småbrekke
Source
PLoS One. 2017;12(11):e0187423
Date
2017
Language
English
Publication Type
Article
Keywords
Dose-Response Relationship, Drug
Humans
Multiple Sclerosis - drug therapy
Naltrexone - therapeutic use
Norway
Abstract
Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate that LDN may have beneficial effects in MS and other autoimmune diseases. If proven efficacious, it would be a cheap and safe alternative to the expensive treatments currently recommended for MS. We investigated whether a sudden increase in LDN use in Norway in 2013 was followed by changes in dispensing of other medications used to treat MS. We performed a quasi-experimental before-and-after study based on population data from the Norwegian Prescription Database (NorPD). We included all patients that collected at least one LDN prescription in 2013, and had collected at least two medications with a reimbursement code for MS, or collected a medication with MS as the only indication in 2009 or 2010. Outcomes were differences in cumulative dispensed doses and incidence of users of disease modifying MS therapies, and medications used to treat MS symptoms two years before and two years after dispensing the initial LDN prescription. The eligible 341 patients collected 20 921 prescriptions in the observation period. Apart from changes in line with general trends in MS therapy in Norway, there was no difference in neither dispensed cumulative doses or number of prevalent users of MS specific medication. Initiation of LDN was not followed by reductions of other medications used to treat symptoms associated with MS.
Notes
Cites: Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):685-69328370746
Cites: Mult Scler J Exp Transl Clin. 2016 Sep 29;2:205521731667224228607740
Cites: Neurol Neuroimmunol Neuroinflamm. 2014 Aug 21;1(3):e2525340078
Cites: Tidsskr Nor Laegeforen. 2011 May 6;131(8):844-621556092
Cites: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD00186721154349
Cites: Curr Pharm Des. 2010;16(19):2091-720482515
Cites: Med Hypotheses. 2005;64(4):721-415694688
Cites: Cochrane Database Syst Rev. 2011 Apr 13;(4):CD00133321491383
Cites: Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):136-14227670755
Cites: Pain. 2008 Jul;137(1):96-11117928147
Cites: Mult Scler. 2014 Nov;20(13):1783-724534079
Cites: Mult Scler. 2010 Aug;16(8):964-920534644
Cites: Ann Neurol. 2010 Aug;68(2):145-5020695007
Cites: Med Hypotheses. 2009 Mar;72(3):333-719041189
PubMed ID
29099849 View in PubMed
Less detail

[Clinical significance of the chemotherapy dosage in gastric cancer]

https://arctichealth.org/en/permalink/ahliterature20914
Source
Klin Khir. 1999;(5):47-51
Publication Type
Article
Date
1999

[Analgesics: use, poisonings, too much?].

https://arctichealth.org/en/permalink/ahliterature215806
Source
Ugeskr Laeger. 1995 Feb 13;157(7):865
Publication Type
Article
Date
Feb-13-1995
Author
J S Schou
J P Kampmann
Source
Ugeskr Laeger. 1995 Feb 13;157(7):865
Date
Feb-13-1995
Language
Danish
Publication Type
Article
Keywords
Analgesics - administration & dosage - poisoning
Denmark
Dose-Response Relationship, Drug
Drug Utilization
Humans
Risk factors
Notes
Comment In: Ugeskr Laeger. 1995 Apr 3;157(14):20227740649
PubMed ID
7646654 View in PubMed
Less detail

[Morphological changes in the organs of the progeny of female rats poisoned with polychloropinene]

https://arctichealth.org/en/permalink/ahliterature66086
Source
Pediatr Akus Ginekol. 1977 Dec;(6):44-6
Publication Type
Article
Date
Dec-1977

[Biopharmaceutical characteristics of pediatric pressed paracetamol suppositories]

https://arctichealth.org/en/permalink/ahliterature42716
Source
Farm Zh. 1975 Mar-Apr;(2):81-3
Publication Type
Article

[Nanopharmacology: experimental and clinic aspect]

https://arctichealth.org/en/permalink/ahliterature90409
Source
Lik Sprava. 2008 Apr-Jun;(3-4):104-9
Publication Type
Article
Author
Chekman I S
Source
Lik Sprava. 2008 Apr-Jun;(3-4):104-9
Language
Ukrainian
Publication Type
Article
Keywords
Dosage Forms
Dose-Response Relationship, Drug
Nanotechnology
Pharmaceutical Preparations - administration & dosage
Technology, Pharmaceutical - methods
Abstract
The literature data and own investigations of the use of the nanotechnologies in medicine have been analyzed in the article. First investigations in the field of nanotechnology made the basis of new decisions in medicine, pharmacology, gene engineering and robot technology. Miniaturisation defines new chemical, physical and biological characteristics of biological objects, which differ from macroobject's characteristics. Study of this unique properties allows developing new technologies and methods in medicine. Nanomedications are used for diagnostic of different conditions, in the first place, cancer diseases. Nanoparticles can be mediators of effective substations or be active drug components. The use of nanotechnology allows reducing the dose of medicine and makes the treatment more safe. Fulerens, nano dispersible silica oxide, nanocaps, liposoms, created by nanotechnology are used in medical practice. It was established that suspension of nano dispersible silica oxide decreases toxicity of antituberculosis drugs, chemical substances of different structure.
PubMed ID
19145830 View in PubMed
Less detail

Letter: Alcohol and organic disease: calculation of consumption.

https://arctichealth.org/en/permalink/ahliterature251393
Source
Can Med Assoc J. 1976 Jan 24;114(2):109-10
Publication Type
Article
Date
Jan-24-1976
Author
E M Sellers
Source
Can Med Assoc J. 1976 Jan 24;114(2):109-10
Date
Jan-24-1976
Language
English
Publication Type
Article
Keywords
Adult
Alcohol Drinking
Alcoholism - mortality
Canada
Chronic Disease
Dose-Response Relationship, Drug
Humans
Male
Middle Aged
Notes
Cites: Q J Stud Alcohol. 1972 Mar;33(1):171-854551020
PubMed ID
1253040 View in PubMed
Less detail

[Risk of overvaccination against tetanus--who is deciding: the National Board of Health and Welfare or the manufacturer?].

https://arctichealth.org/en/permalink/ahliterature231242
Source
Lakartidningen. 1989 Feb 22;86(8):615-6
Publication Type
Article
Date
Feb-22-1989
Author
E. Rabo
Source
Lakartidningen. 1989 Feb 22;86(8):615-6
Date
Feb-22-1989
Language
Swedish
Publication Type
Article
Keywords
Dose-Response Relationship, Drug
Drug Industry
Humans
Legislation, Drug
Risk factors
Sweden
Tetanus Toxoid - administration & dosage
PubMed ID
2921906 View in PubMed
Less detail

[Efficacy of water fluoridation for the purpose of preventing dental caries]

https://arctichealth.org/en/permalink/ahliterature41983
Source
Stomatologiia (Mosk). 1977 May-Jun;56(3):70-2
Publication Type
Article

1468 records – page 1 of 147.